Effectiveness of Rapid Antigen Testing of Students for COVID-19 in Reducing Absences From Schools in Bangladesh
Evaluating the Effectiveness of an Intervention Involving Rapid Antigen Testing of Students for COVID-19 in Reducing Absences From Schools in Bangladesh
1 other identifier
interventional
1,141
1 country
1
Brief Summary
The goal of this trial is to evaluate the impact of different testing strategies with Rapid Antigen Testing (RAT) on reduction of school absences. RATs are relatively inexpensive, fast, and can be performed at the point of care. Provision of testing in schools will allow rapid identification and isolation of individuals infected with Covid-19. This will likely reduce COVID-19 transmission, as well as allow symptomatic COVID-19 negative students to return to classroom, avoiding the 10-days isolation period. If proven successful, the lessons from this study can be translated to schools in similar settings. While several testing strategies have been proposed and evaluated in developed countries, no studies have evaluated the role of testing for safe operation of schools or reducing absenteeism in developing country contexts.The lessons learned from this study is likely to inform government policy regarding the provision of testing in school. Study design: Cluster randomized trial School types: Three types based on testing:
- Intervention school-1: Test all symptomatic students, teachers, and support staff ; and track symptoms and absenteeism
- Intervention school-2: Test all students, teachers, and support staff every 3 days, irrespective of symptoms (also test whenever develops symptoms) and track symptoms and absenteeism
- Control school: Only track the students for symptom notification and absenteeism
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2022
CompletedFirst Submitted
Initial submission to the registry
November 25, 2022
CompletedFirst Posted
Study publicly available on registry
December 29, 2022
CompletedDecember 29, 2022
December 1, 2022
2 months
November 25, 2022
December 25, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
The number of days absent
Daily data on school absence was collected prospectively from the school authorities and the cause of absence was collected from the students.
10 Weeks
Secondary Outcomes (1)
COVID-19 positivity
10 Weeks
Study Arms (3)
School-type 1, intervention school-1
EXPERIMENTALWe will test all symptomatic students, teachers, and support staff ; and track students symptoms and absenteeism
School-type 2, intervention school-2
EXPERIMENTALWe will test all students, teachers, and support staff every 3 days, irrespective of symptoms (also test whenever develops symptoms) and track students symptoms and absenteeism
In School-type 3, control school
EXPERIMENTALWe will not do any test, only track the students for symptom notification and absenteeism
Interventions
COVID-19 RAT intervention done among the school students to see if RAT test can play a role in reducing absenteeism. School type-1-only for symptomatic participants, School type-2-Serial testing at three days interval for all participants and School type-3 got no testing.
Eligibility Criteria
You may qualify if:
- A day school (not residential), with at least 50 students per classroom that follows the national curriculum in either Bangla or English instruction
- Students of class Nine, Ten and Eight
- Providing written consent for participation (both student and Guardian)
You may not qualify if:
- Not providing written consent for participation (both student and Guardian)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Icddr,B
Dhaka, 1212, Bangladesh
Study Officials
- PRINCIPAL INVESTIGATOR
Arifa Nazneen, MBBS, MPH
International Centre for Diarrhoeal Disease Research, Bangladesh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 25, 2022
First Posted
December 29, 2022
Study Start
May 18, 2022
Primary Completion
July 30, 2022
Study Completion
July 30, 2022
Last Updated
December 29, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share